All 260 PsA patients (210 PGRN Ab-negative, 50 PGRN Ab-positive) were stratified according to their clinical manifestations, such as enthesitis, dactylitis, axial manifestations and erosive-proliferative joint damage. This evidence concerns the gene GRN and enthesitis.